COVID-19 : Athlete Q&A / World Anti-Doping Agency (WADA). - Montreal : WADA, 2020
The World Anti-Doping Agency (WADA) responded to athlete queries concerning anti-doping in light of the ongoing COVID-19 pandemic by publishing a Question and Answer (Q&A) document that it developed in consultation with its Athlete Committee. This follows on from WADA’s COVID-19 guidance that was issued on 20 March to Anti-Doping Organizations (ADOs) worldwide.
The Q&A covers issues such as:
- Ongoing testing
- Minimizing the risk of contracting or transmitting the virus
- Filing of whereabouts information
- Validating Therapeutic Use Exemptions
- Maintaining the integrity of the anti-doping system
- Refusing to comply with testers at this time
WADA will continue to liaise with athletes and ADOs in the interest of publishing updates regarding the Agency’s response to COVID-19 as the situation evolves.
